[ad_1]
The first phase of testing the Italian Rottapharm Takis vaccine in humans has started in Italy. The first dose will be administered to a 21-year-old at San Gerardo Hospital in Monza.
The young man has volunteered. After vaccination, you will wait two days to see if there are any side effects. After that, two more volunteers will be vaccinated, and in the following days two more and so on. In total, 20 people will receive doses of the Italian vaccine at the start of the experiment. According to experts, this vaccine is different from others because it is based on DNA, the stable molecule, unlike those mRNAs, and can be modified very quickly against different variants of the coronavirus.
The study of the first phase of the vaccine is also underway in Spallanzani in Rome, as well as at the Pascale Institute in Naples, under the authorization of Aifa and the Spallanzani Ethics Committee. This development comes at a time when new variants are turning into major concern for the neighboring country, as many regions are changing color, with Lombardy, Marche and Piedmont in orange and Basilicata and Molise in red. The Minister of Health, Roberto Speranza, has warned that the coming weeks will not be easy, as new cases are growing significantly and said that the virus we are facing is insidious and very complicated, so he asked the citizens to be rigorous, respect, and attention to rules.
top channel
[ad_2]
Source link
